N Brown

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. doi request reprint Renal Embolization and Urothelial Sclerotherapy for Recurrent Obstructive Urosepsis and Intractable Haematuria from Upper Tract Urothelial Carcinoma
    Nicholas Brown
    Department of Interventional Radiology, St Vincent s Hospital, Melbourne, Australia
    Cardiovasc Intervent Radiol 39:467-71. 2016
  2. doi request reprint Percutaneous Placement of Permanent Metallic Stents in the Cystic Duct to Treat Obstructive Cholecystitis
    Nicholas I Brown
    Department of Vascular and Interventional Radiology, St Vincent s Hospital, Melbourne, 59 Victoria Parade, Fitzroy VIC 3065, Australia Electronic address
    J Vasc Interv Radiol 26:1860-5. 2015
  3. pmc The French and their hernias: prospective radiological differentiation of de Garengeot from other groin hernias
    Nicholas Brown
    Department of Medical Imaging, Royal Brisbane and Women s Hospital, Brisbane, Australia
    J Radiol Case Rep 7:16-21. 2013
  4. doi request reprint Knowledge of medical imaging radiation dose and risk among doctors
    Nicholas Brown
    Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    J Med Imaging Radiat Oncol 57:8-14. 2013
  5. doi request reprint Evaluating the true clinical utility of the red dot system in radiograph interpretation
    Nicholas Brown
    Medical Imaging, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    J Med Imaging Radiat Oncol 56:510-3. 2012
  6. doi request reprint Antivenom: the most cost-effective treatment in the world?
    N Brown
    The Institute of Biotechnology, University of Cambridge, Cambridge, UK
    Toxicon 55:1405-7. 2010

Collaborators

Detail Information

Publications6

  1. doi request reprint Renal Embolization and Urothelial Sclerotherapy for Recurrent Obstructive Urosepsis and Intractable Haematuria from Upper Tract Urothelial Carcinoma
    Nicholas Brown
    Department of Interventional Radiology, St Vincent s Hospital, Melbourne, Australia
    Cardiovasc Intervent Radiol 39:467-71. 2016
    ....
  2. doi request reprint Percutaneous Placement of Permanent Metallic Stents in the Cystic Duct to Treat Obstructive Cholecystitis
    Nicholas I Brown
    Department of Vascular and Interventional Radiology, St Vincent s Hospital, Melbourne, 59 Victoria Parade, Fitzroy VIC 3065, Australia Electronic address
    J Vasc Interv Radiol 26:1860-5. 2015
    ..Symptoms resolved in all cases, and stents remained patent for as long as 22 months. This procedure may be an effective alternative to cholecystectomy or long-term gallbladder drainage for patients in inoperable condition. ..
  3. pmc The French and their hernias: prospective radiological differentiation of de Garengeot from other groin hernias
    Nicholas Brown
    Department of Medical Imaging, Royal Brisbane and Women s Hospital, Brisbane, Australia
    J Radiol Case Rep 7:16-21. 2013
    ..Despite this, we present only the fourth published case of prospective CT diagnosis of de Garengeot hernia...
  4. doi request reprint Knowledge of medical imaging radiation dose and risk among doctors
    Nicholas Brown
    Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    J Med Imaging Radiat Oncol 57:8-14. 2013
    ..Doctors across all medical specialties and experience levels were surveyed to determine their knowledge of radiation doses and potential risks associated with some diagnostic imaging...
  5. doi request reprint Evaluating the true clinical utility of the red dot system in radiograph interpretation
    Nicholas Brown
    Medical Imaging, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    J Med Imaging Radiat Oncol 56:510-3. 2012
    ..It is important that all systems within medical imaging add value, and this audit evaluates the accuracy and clinical value of the 'red dot' system, particularly in the critical area of detecting undisplaced fractures...
  6. doi request reprint Antivenom: the most cost-effective treatment in the world?
    N Brown
    The Institute of Biotechnology, University of Cambridge, Cambridge, UK
    Toxicon 55:1405-7. 2010
    ..These advances may lead to antivenom becoming one of the most cost-effective treatments available to modern medicine, and provides strong justification for its inclusion in international health funding initiatives...